Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

The Fourth Annual BioNJ CEO Summit Took It OVER the Top; BIO CEO Jim Greenwood Keynotes

10/7/2016

0 Comments

 
Trenton, NJ ― The Fourth Annual BioNJ CEO Summit that took place last week, September 23 at the Bridgewater Marriott, brought together some of the most influential leaders in the life sciences industry to share their knowledge, experiences and views on today’s challenging and evolving market access and commercialization environment.
 
The stellar lineup of speakers dove into the issues and considerations that need to be addressed along the development continuum, including raising capital, pricing, post-launch and politics.
 
“Because Patients Can’t WaitSM, bringing new treatments and drugs to the Patients who need them is always at the heart of our programs,” said BioNJ President and CEO Debbie Hart.
 
“And, this year’s CEO Summit reflected that by facilitating vital conversations that need to happen to ensure ongoing medical innovation,” Hart continued.  “Today’s environment is increasingly complex and the uncertainty of the election makes it even more ominous.”
 
“A special thank you to our committed volunteer committee chaired by BioNJ Board Member Al Altomari of Agile Therapeutics and Jan Campbell of Korn Ferry, and our insightful friends at McKinsey & Company who played an integral role in building this year’s program,” added Hart.
​One of the many highlights of the Summit included a luncheon presentation by Biotechnology Innovation Organization (BIO) President and CEO James Greenwood.
 
During his Keynote address, Mr. Greenwood introduced ” Innovation Saves,” BIO’s multi-media campaign focused on biopharmaceutical innovation and its’ unique ability to help save lives and money.
 
He rounded out his Keynote with a fireside chat led by Hart on his predictions on the 2016 Presidential Race and its impact on future medical innovation, access and pricing.
 
The diverse roster of speakers included:
 
  • Murray Aitken, Sr.Vice President & Executive Director, IMS Institute for Healthcare Informatics
  • Meg Alexander, Head, Issues Management Practice, inVentiv Health
  • Mark J. Alles, CEO, Celgene Corporation
  • Fedora Baloiu, Head of the Biopharmaceutical Practice, Houlihan Lokey’s Healthcare Group
  • Geert Cauwenbergh, Ph.D., Med. Sc., CEO, RXi Pharmaceuticals Corporation
  • Brett Davis, Principal, Deloitte Consulting & General Manager, ConvergeHEALTH
  • James Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)
  • Robert Goldberg, Ph.D., Vice President and Co-Founder, Center for Medicine in the Public Interest
  • Sam Hall, Ph.D., Principal, Apple Tree Partners
  • Karin Hehenberger, M.D., Ph.D., Founder, Chairman & CEO, LYFEBULB
  • Jesper Høiland, Executive Vice President, U.S., Novo Nordisk
  • Lindsay McKenna, Ph.D., Associate Principal, McKinsey & Company
  • Daniel O’Connor, President, CEO & Director, Advaxis
  • Stelios Papadopoulos, Ph.D., Chairman, Biogen
  • Linda Pissott Reig, Esq., Shareholder, Buchanan Ingersoll and Rooney PC
  • Carlo Rizzuto, Ph.D., Partner, Versant Ventures
  • David Schwartz, Partner, DLA Piper
  • Susan Shiff, Ph.D., Sr. Vice President & Head of the Center for Observational & Real World Evidence, Merck & Co.
  • Jeffrey Stoll, Ph.D., Vice President, EY
  • BJ Tevelow, M.D., Sr. Partner, McKinsey & Company
  • Harry J. Travis, President & CEO, eTect, Inc., & Former Vice President, Aetna Specialty & Home Delivery Pharmacy
  • Robert Ward, President & CEO, Radius Health
  • Dieter Weinand, Member of the Board of Management of Bayer AG, President Pharmaceuticals & Chairman of the Board of Management of Bayer Pharma AG
 
Please visit www.BioNJ.org to learn about BioNJ’s upcoming events, including its inaugural Patient Advocacy Summit on November 4 at Celgene, the Second Annual Inspiring Women in STEM Conference on December 2 at Sanofi and our first-ever Value of Medical Innovation Workshop on December 8 and Amicus Therapeutics.
 
About BioNJ
 
BioNJ, The Gateway to Health, is a network of more than 400 Members representing research-based life sciences companies and stakeholders dedicated to propelling a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount.
 
Because Patients Can’t WaitSM, BioNJ supports its Members in the discovery, development and commercialization of therapies and cures that save and improve lives and lessen the burden of illness and disease to society by driving capital formation, fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education and offering a cost-saving array of critical commercial resources.
 
For more information about BioNJ, please visit www.BioNJ.org.
 
 
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
222 West State Street
Suite 302
Trenton, NJ 08608
732-729-9619